Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kelechi K. Olu"'
Autor:
Benjamin Kasenda, Erik von Elm, John J You, Anette Blümle, Yuki Tomonaga, Ramon Saccilotto, Alain Amstutz, Theresa Bengough, Joerg J Meerpohl, Mihaela Stegert, Kelechi K Olu, Kari A O Tikkinen, Ignacio Neumann, Alonso Carrasco-Labra, Markus Faulhaber, Sohail M Mulla, Dominik Mertz, Elie A Akl, Dirk Bassler, Jason W Busse, Ignacio Ferreira-González, Francois Lamontagne, Alain Nordmann, Viktoria Gloy, Heike Raatz, Lorenzo Moja, Shanil Ebrahim, Stefan Schandelmaier, Xin Sun, Per O Vandvik, Bradley C Johnston, Martin A Walter, Bernard Burnand, Matthias Schwenkglenks, Lars G Hemkens, Heiner C Bucher, Gordon H Guyatt, Matthias Briel
Publikováno v:
PLoS Medicine, Vol 13, Iss 6, p e1002046 (2016)
BackgroundLittle is known about publication agreements between industry and academic investigators in trial protocols and the consistency of these agreements with corresponding statements in publications. We aimed to investigate (i) the existence and
Externí odkaz:
https://doaj.org/article/0ab98bba00b0428f95ad46102f45e46b
Autor:
Erik von Elm, Roy Frei, Arnav Agarwal, Reem Alturki, Stefan Schandelmaier, Lotty Hooft, Belinda von Niederhäusern, Matthias Briel, Neera Bhatnagar, Kelechi K Olu
Publikováno v:
Journal of Clinical Epidemiology
Europe PubMed Central
Journal of Clinical Epidemiology, 81, 56. Elsevier USA
Europe PubMed Central
Journal of Clinical Epidemiology, 81, 56. Elsevier USA
Background One quarter of randomized clinical trials (RCTs) are prematurely discontinued and frequently remain unpublished. Trial registries can document whether a trial is ongoing, suspended, discontinued, or completed and therefore represent an imp
Autor:
Reem Alturki, Belinda von Niederhäusern, Matthias Briel, Stefan Schandelmaier, Kelechi K Olu, Arnav Agarwal, Jakub Surina, Alain Amstutz, Roy Frei, Erik von Elm
Publikováno v:
BMJ Open
BMJ open, vol. 7, no. 7, pp. e016216
BMJ open, vol. 7, no. 7, pp. e016216
Objective The Swiss National Science Foundation (SNSF) promotes academic excellence through competitive selection of study proposals and rigorous evaluation of feasibility, but completion status and publication history of SNSF-supported randomised cl
Autor:
Lars G. Hemkens, Alain J Nordmann, Armon Arpagaus, Kelechi K Olu, Matthias Briel, Ramon Saccilotto, Stefan Schandelmaier
Publikováno v:
The Cochrane Library
Background Nicotinic acid (niacin) is known to decrease LDL-cholesterol, and triglycerides, and increase HDL-cholesterol levels. The evidence of benefits with niacin monotherapy or add-on to statin-based therapy is controversial. Objectives To assess
Autor:
Matthias Schwenkglenks, Heike Raatz, Per Olav Vandvik, Yuki Tomonaga, Dominik Mertz, Erik von Elm, Kelechi K Olu, Gordon H. Guyatt, Bernard Burnand, Elie A. Akl, Shanil Ebrahim, Matthias Briel, Sohail M. Mulla, Ignacio Neumann, Alonso Carrasco-Labra, Stefan Schandelmaier, Alain J Nordmann, Markus Faulhaber, Joerg J Meerpohl, Heiner C. Bucher, Alain Amstutz, Lars G. Hemkens, Lorenzo Moja, Theresa Bengough, Anette Bluemle, Ramon Saccilotto, Ignacio Ferreira-González, Bradley C. Johnston, Rachel Rosenthal, John J. You, Mihaela Stegert, Benjamin Kasenda, Kari A.O. Tikkinen, Viktoria Gloy, Martin A. Walter, Dirk Bassler, Jason W. Busse, Francois Lamontagne, Xin Sun
Objectives To determine the proportion of pediatric randomized controlled trials (RCTs) that are prematurely discontinued, examine the reasons for discontinuation, and compare the risk for recruitment failure in pediatric and adult RCTs. Study design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbdd0af1cbd14639a20e0533b1a1fadd
http://hdl.handle.net/10138/236976
http://hdl.handle.net/10138/236976
Autor:
Gordon H. Guyatt, Kari A.O. Tikkinen, Jason W. Busse, Per Olav Vandvik, Ramon Saccilotto, Francois Lamontagne, Yuki Tomonaga, Elie A. Akl, Heiner C. Bucher, Heike Raatz, Erik von Elm, Lorenzo Moja, Matthias Schwenkglenks, Theresa Bengough, Anette Blümle, Shanil Ebrahim, Mihaela Stegert, Dirk Bassler, Bernard Burnand, Stefan Schandelmaier, Matthias Briel, Bradley C. Johnston, Xin Sun, John J. You, Alonso Carrasco-Labra, Viktoria Gloy, Dominik Mertz, Benjamin Kasenda, Markus Faulhaber, Lars G. Hemkens, Alain Amstutz, Ignacio Ferreira-González, Sohail M. Mulla, Martin A. Walter, Kelechi K Olu, Ignacio Neumann, Alain J Nordmann, Joerg J Meerpohl
Publikováno v:
Plos Medicine, vol. 13, no. 6, pp. e1002046
Kasenda, Benjamin; von Elm, Erik; You, John J; Blümle, Anette; Tomonaga, Yuki; Saccilotto, Ramon; Amstutz, Alain; Bengough, Theresa; Meerpohl, Joerg J; Stegert, Mihaela; Olu, Kelechi K; Tikkinen, Kari A O; Neumann, Ignacio; Carrasco-Labra, Alonso; Faulhaber, Markus; Mulla, Sohail M; Mertz, Dominik; Akl, Elie A; Bassler, Dirk; Busse, Jason W; ... (2016). Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials. PLoS medicine, 13(6), e1002046. Public Library of Science 10.1371/journal.pmed.1002046
PLOS Medicine
PLoS Medicine, Vol 13, Iss 6, p e1002046 (2016)
PLoS Medicine
Kasenda, Benjamin; von Elm, Erik; You, John J; Blümle, Anette; Tomonaga, Yuki; Saccilotto, Ramon; Amstutz, Alain; Bengough, Theresa; Meerpohl, Joerg J; Stegert, Mihaela; Olu, Kelechi K; Tikkinen, Kari A O; Neumann, Ignacio; Carrasco-Labra, Alonso; Faulhaber, Markus; Mulla, Sohail M; Mertz, Dominik; Akl, Elie A; Bassler, Dirk; Busse, Jason W; ... (2016). Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials. PLoS medicine, 13(6), e1002046. Public Library of Science 10.1371/journal.pmed.1002046
PLOS Medicine
PLoS Medicine, Vol 13, Iss 6, p e1002046 (2016)
PLoS Medicine
Background Little is known about publication agreements between industry and academic investigators in trial protocols and the consistency of these agreements with corresponding statements in publications. We aimed to investigate (i) the existence an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a7513b093608c94459014bed114cb47
https://www.zora.uzh.ch/id/eprint/128301/
https://www.zora.uzh.ch/id/eprint/128301/
Autor:
Viktoria Gloy, Kelechi K Olu, Dominik Glinz, Mark Nidorf, Hannah Ewald, Lars G. Hemkens, Armon Arpagaus, Matthias Briel, Alain J Nordmann
Publikováno v:
The Cochrane Library
Background Colchicine is an anti-inflammatory drug that is used for a wide range of inflammatory diseases. Cardiovascular disease also has an inflammatory component but the effects of colchicine on cardiovascular outcomes remain unclear. Previous saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e276f70324f217a01460f95a242b5cb0
https://europepmc.org/articles/PMC6956668/
https://europepmc.org/articles/PMC6956668/
Autor:
Theresa Bengough, Deborah J. Cook, Erik von Elm, Shanil Ebrahim, Mihaela Stegert, John J. You, Alonso Carrasco-Labra, Alain Amstutz, Matthias Briel, Maureen O. Meade, Matthias Schwenkglenks, Bradley C. Johnston, Per Olav Vandvik, Yuki Tomonaga, Viktoria Gloy, Heike Raatz, Elie A. Akl, Bernard Burnand, Stefan Schandelmaier, Jason W. Busse, Martin A. Walter, Francois Lamontagne, Ramon Saccilotto, Sohail M. Mulla, Heiner C. Bucher, Anette Blümle, Dirk Bassler, Lorenzo Moja, Xin Sun, Lars G. Hemkens, Ignacio Ferreira-González, Rachel Rosenthal, Markus Faulhaber, Dominik Mertz, Alain J Nordmann, Joerg J Meerpohl, Kelechi K Olu, Benjamin Kasenda, Kari A.O. Tikkinen, Ignacio Neumann
Publikováno v:
Schandelmaier, Stefan; von Elm, Erik; You, John J; Blümle, Anette; Tomonaga, Yuki; Lamontagne, Francois; Saccilotto, Ramon; Amstutz, Alain; Bengough, Theresa; Meerpohl, Joerg J; Stegert, Mihaela; Olu, Kelechi K; Tikkinen, Kari A O; Neumann, Ignacio; Carrasco-Labra, Alonso; Faulhaber, Markus; Mulla, Sohail M; Mertz, Dominik; Akl, Elie A; Sun, Xin; ... (2016). Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study. Critical care medicine, 44(1), pp. 130-137. Lippincott Williams & Wilkins 10.1097/CCM.0000000000001369
Critical Care Medicine
Critical Care Medicine
OBJECTIVES Randomized clinical trials that enroll patients in critical or emergency care (acute care) setting are challenging because of narrow time windows for recruitment and the inability of many patients to provide informed consent. To assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cbdf284232d5dac70aee7a648bbdb10
Autor:
Benjamin Kasenda, Arnav Agarwal, Erik von Elm, Matthias Briel, Reem Alturki, Kelechi K Olu, Stefan Schandelmaier, Neera Bhatnagar
Publikováno v:
Europe PubMed Central
Journal of Clinical Epidemiology
Journal of Clinical Epidemiology
OBJECTIVE To collect and classify reported reasons for recruitment failure in discontinued randomized controlled trials (RCTs) and to assess reporting quality. METHODS We systematically searched MEDLINE and EMBASE (2010-2014) and a previous cohort of
Autor:
Lars G. Hemkens, Armon Arpagaus, Alain J Nordmann, Hannah Ewald, Viktoria Gloy, Kelechi K Olu, Mark Nidorf, Matthias Briel, Dominik Glinz
Publikováno v:
Heart (British Cardiac Society). 102(8)
Colchicine is an old anti-inflammatory drug that has shown substantial cardiovascular benefits in recent trials. We systematically reviewed cardiovascular benefits and harms of colchicine in any population and specifically in patients with high cardi